1.
Jimeno C, Kho S, de los Santos GK, Buena-Bobis N, Villa M. The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes. J ASEAN Fed Endocr Soc [Internet]. 2018Sep.30 [cited 2024Mar.29];33(2):114. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/422